Paper2804541
Comparative effects of bepridil, its quaternary derivative CERM 11888 and verapamil on caffeine-induced contracture in ferret hearts.
Leboeuf J and 3 others. Br J Pharmacol, 1989. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Comparative effects of bepridil, its quaternary derivative CERM 11888 and verapamil on caffeine-induced contracture in ferret hearts. Papers, record 2804541. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2804541
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparative effects of bepridil, its quaternary derivative CERM 11888 and verapamil on caffeine-induced contracture in ferret hearts.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bepridil | Major topic |
| Caffeine | Major topic |
| Myocardial Contraction | Major topic |
| Verapamil | Major topic |
| Animals | |
| Ferrets | |
| In Vitro Techniques |
Source PubMed
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6981516 | Differential actions of calcium antagonists on calcium binding to cardiac sarcolemma. | Eur J Pharmacol | 1982 | https://conductscience.org/library/papers/6981516 | PubMed |
| 2 | 6811156 | Cellular calcium turnover in the perfused rat heart: modulation by caffeine and procaine. | Circ Res | 1982 | https://conductscience.org/library/papers/6811156 | PubMed |
| 3 | 6601581 | Nifedipine, diltiazem, bepridil and verapamil uptakes into cardiac and smooth muscles. | Eur J Pharmacol | 1983 | https://conductscience.org/library/papers/6601581 | PubMed |
| 4 | 6603218 | Uptake of bepridil into isolated ventricular myocytes. Retention by actin. | Biochem Pharmacol | 1983 | https://conductscience.org/library/papers/6603218 | PubMed |
| 5 | 6353942 | Control of cardiac contractility at the cellular level. | Am J Physiol | 1983 | https://conductscience.org/library/papers/6353942 | PubMed |
| 6 | 6608945 | Uptake of calcium antagonistic drugs into muscles as related to their lipid solubilities. | Biochem Pharmacol | 1984 | https://conductscience.org/library/papers/6608945 | PubMed |
| 7 | 6231932 | Effects of bepridil on Ca2+ uptake by cardiac mitochondria. | Biochem Pharmacol | 1984 | https://conductscience.org/library/papers/6231932 | PubMed |
| 8 | 6234179 | Effects of verapamil, diltiazem, nisoldipine and felodipine on sarcoplasmic reticulum. | Eur J Pharmacol | 1984 | https://conductscience.org/library/papers/6234179 | PubMed |
| 9 | 6088765 | Effects on calmodulin of bepridil, an antianginal agent. | J Pharmacol Exp Ther | 1984 | https://conductscience.org/library/papers/6088765 | PubMed |
| 10 | 6492005 | The effects of caffeine on tension development and intracellular calcium transients in rat ventricular muscle. | J Physiol | 1984 | https://conductscience.org/library/papers/6492005 | PubMed |
| 11 | 3155615 | Stimulation of canine cardiac sarcoplasmic reticulum Ca2+ uptake by dihydropyridine Ca2+ antagonists. | Biochem Pharmacol | 1985 | https://conductscience.org/library/papers/3155615 | PubMed |
| 12 | 3155893 | Second-generation calcium antagonists: search for greater selectivity and versatility. | Am J Cardiol | 1985 | https://conductscience.org/library/papers/3155893 | PubMed |
| 13 | 3872052 | Comparative electrophysiologic profiles of calcium antagonists with particular reference to bepridil. | Am J Cardiol | 1985 | https://conductscience.org/library/papers/3872052 | PubMed |
| 14 | 3874780 | Antifibrillatory actions of bepridil and butyl-MDI, two intracellular calcium antagonists. | Eur J Pharmacol | 1985 | https://conductscience.org/library/papers/3874780 | PubMed |
| 15 | 2413942 | Effects of selective channel blocking agents on contractions and action potentials in K+-depolarized guinea-pig atria. | Br J Pharmacol | 1985 | https://conductscience.org/library/papers/2413942 | PubMed |
| 16 | 2414784 | Bepridil: a review of its pharmacology and clinical efficacy as an anti-anginal agent with anti-arrhythmic properties. | Pharmatherapeutica | 1985 | https://conductscience.org/library/papers/2414784 | PubMed |
| 17 | 2933041 | Slow calcium channel blockers and calmodulin. Effect of felodipine, nifedipine, prenylamine and bepridil on cardiac sarcolemmal calcium pumping ATPase. | Biochem Pharmacol | 1985 | https://conductscience.org/library/papers/2933041 | PubMed |
| 18 | 3484629 | The binding of the calcium channel blocker, bepridil, to calmodulin. | Biochem Pharmacol | 1986 | https://conductscience.org/library/papers/3484629 | PubMed |
| 19 | 2420970 | Bepridil block of cardiac calcium and sodium channels. | J Pharmacol Exp Ther | 1986 | https://conductscience.org/library/papers/2420970 | PubMed |
| 20 | 3486771 | Effects of bepridil and of its quaternary derivative on rat tail artery. | Eur J Pharmacol | 1986 | https://conductscience.org/library/papers/3486771 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2804541
GET https://conductscience.org/api/papers/v1/2804541/references?page=2